Speaker Profile
Ph.D., CSO & Co-Founder, IN8bio
Biography
Dr. Lawrence Lamb leads scientific and translational strategy for novel gamma delta T cell therapy initiatives. His initial training in inflammatory lung disease and macrophage function was followed by postdoctoral fellowships in molecular evolution and transplantation immunology at the South Carolina Cancer Center. He was the first to describe the association between relapse-free survival and homeostatic gamma delta T cell recovery in high-risk leukemia patients. As an Associate Professor and later Professor of Medicine at the University of Alabama at Birmingham, Dr. Lamb developed the scientific support for chemotherapy resistant gamma delta T cell-based immunotherapy for high-grade brain tumors. Over the course of his career, Dr. Lambs work has been funded by the NCI, NHLBI, NCRR, NINDS, American Red Cross, Childrens Oncology Group, the Elsa Pardee Foundation, the Leukemia and Lymphoma Society, and the National Brain Tumor Foundation's Samuel Gerson chair for glioblastoma research.
Session Abstract – PMWC 2025 Silicon Valley
Track Chair: Maggie Chapman, Labcorp
- Cross-Application of Oncology Drugs in Rare Diseases
- Razelle Kurzrock, Medical College of Wisconsin
- PMWC 2025 Award Ceremony
Luminary Honoree: David R. Liu, Broad Institute & Crystal Mackal, Stanford University
Pioneer Honoree: Drew Weissman, Penn Medicine
- Keynote: Base Editing, Prime Editing, and Targeted Gene Integration: Precision Therapeutic Genome Editingn
- David R. Liu, Broad Institute
- Breakthroughs in Cancer Immunotherapy: mRNA Vaccines and CAR T-Cell Advances (PANEL)
Chair: Rick Klausner, Altos Labs
- Drew Weissman, Penn Medicine
- Ira Mellman, Formelly with Genentech
- Crystal Mackal, Stanford University - Next-Generation ADCs: Challenges and Innovations in Immunotherapy Combinations (PANEL)
Chair: Sandhya Girish, Gilead
- Bin Liu, UCSF
- Strategic IP Management in Cell and Gene Therapy: Navigating Legal and Practical Challenges
- Janet Xiao, Morrison & Foerster LLP
- Advances in Allogeneic Cell Therapies: Overcoming Hurdles and Expanding Applications (PANEL)
Chair: Elliot Norry, Adaptimmune
- Larry Lamb, IN8bio
- Indu Ramachandran, Century Therapeutics - Transforming Cancer Treatment: Stem Cell and Gene Therapy Breakthroughs
Chair: Catriona Jamieson, UCSD Health
- Irv Weisman, Stanford
- Advancements and Future Directions in Therapeutic Ultrasound for Precision Medicine
Chair: Masha Stromme, EXACT Therapeutics
- Bradford Elmer, Sanofi
- John de Groot, UCSF
- Raag Airan, Stanford
